PEREZ ROBERT J 4

What Happened

• Robert J. Perez, a director of Rapport Therapeutics (RAPP), was granted a derivative award covering 15,200 shares on 2026-06-10. The Form 4 reports an acquisition of 15,200 shares at $0.00 (derivative award); no cash changed hands in this filing and no immediate sale occurred.

Key Details

• Transaction date: 2026-06-10; filing date: 2026-06-10 (timely filing).
• Transaction type: Award/Grant (derivative) of 15,200 shares, reported at $0.00.
• Shares owned after transaction: Not disclosed in the provided summary.
• Vesting note (from filer): The shares underlying this option vest on the earlier of (i) June 10, 2027 or (ii) the date of the next Annual Meeting of Stockholders, subject to continued service by the reporting person.
• No indication in the filing of a 10b5-1 plan, tax withholding sale, or immediate cashless exercise.

Context

• This is a derivative award (e.g., option or restricted-equity award) that vests in the future; it does not represent an open-market purchase or sale and should not be interpreted as an immediate change in share ownership or liquidity. The grant is a common form of director compensation and becomes economically relevant only as it vests and depending on any exercise terms or strike price (not reported here).